Cross-Site Scripting (XSS) Vulnerability in BMC Remedy Mid Tier 9.1SP3

CVE-2017-17678 · MEDIUM Severity

CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:C/C:L/I:L/A:N

BMC Remedy Mid Tier 9.1SP3 is affected by cross-site scripting (XSS). A DOM-based cross-site scripting vulnerability was discovered in a legacy utility.

Learn more about our Web Application Penetration Testing UK.